Your browser doesn't support javascript.
loading
Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Directed Radioligand Therapy.
Hartrampf, Philipp E; Mihatsch, Patrick W; Seitz, Anna Katharina; Solnes, Lilja B; Rowe, Steven P; Pomper, Martin G; Kübler, Hubert; Bley, Thorsten A; Buck, Andreas K; Werner, Rudolf A.
Affiliation
  • Hartrampf PE; Department of Nuclear Medicine, University Hospital of Würzburg, Würzburg, Germany; hartrampf_p@ukw.de.
  • Mihatsch PW; Department of Diagnostic and Interventional Radiology, University Hospital of Würzburg, Würzburg, Germany.
  • Seitz AK; Department of Urology and Paediatric Urology, University Hospital of Würzburg, Würzburg, Germany; and.
  • Solnes LB; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Rowe SP; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Pomper MG; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Kübler H; Department of Urology and Paediatric Urology, University Hospital of Würzburg, Würzburg, Germany; and.
  • Bley TA; Department of Diagnostic and Interventional Radiology, University Hospital of Würzburg, Würzburg, Germany.
  • Buck AK; Department of Nuclear Medicine, University Hospital of Würzburg, Würzburg, Germany.
  • Werner RA; Department of Nuclear Medicine, University Hospital of Würzburg, Würzburg, Germany.
J Nucl Med ; 64(8): 1272-1278, 2023 08.
Article in En | MEDLINE | ID: mdl-37290794
ABSTRACT
In patients with prostate cancer scheduled for systemic treatment, being overweight is linked to prolonged overall survival (OS), whereas sarcopenia is associated with shorter OS. We investigated fat-related and body composition parameters in patients undergoing prostate-specific membrane antigen (PSMA)-directed radioligand therapy (RLT) to assess their predictive value for OS.

Methods:

Body mass index (BMI, in kg/m2) and CT-derived body composition parameters (total, subcutaneous, visceral fat area, and psoas muscle area at the L3-L4 level) were determined for 171 patients scheduled for PSMA-directed RLT. After normalization for stature, the psoas muscle index was used to define sarcopenia. Outcome analysis was performed using Kaplan-Meier curves and Cox regression including fat-related and other clinical parameters (Gleason score, C-reactive protein [CRP], lactate dehydrogenase [LDH], hemoglobin, and prostate-specific antigen levels). The Harrell C-index was used for goodness-of-fit analysis.

Results:

Sixty-five patients (38%) had sarcopenia, and 98 patients (57.3%) had increased BMI. Relative to the 8-mo OS in normal-weight men (BMI < 25), overweight men (25 ≥ BMI > 30) and obese men (BMI ≥ 30) achieved a longer OS of 14 mo (hazard ratio [HR], 0.63; 95% CI, 0.40-0.99; P = 0.03) and 13 mo (HR, 0.47; 95% CI, 0.29-0.77; P = 0.004), respectively. Sarcopenia showed no impact on OS (11 vs. 12 mo; HR, 1.4; 95% CI, 0.91-2.1; P = 0.09). Most of the body composition parameters were tightly linked to OS on univariable analyses, with the highest C-index for BMI. In multivariable analysis, a higher BMI (HR, 0.91; 95% CI, 0.86-0.97; P = 0.006), lower CRP (HR, 1.09; 95% CI, 1.03-1.14; P < 0.001), lower LDH (HR, 1.08; 95% CI, 1.03-1.14; P < 0.001), and longer interval between initial diagnosis and RLT (HR, 0.95; 95% CI, 0.91-0.99; P = 0.02) were significant predictors of OS.

Conclusion:

Increased fat reserves assessed by BMI, CRP, LDH, and interval between initial diagnosis and RLT, but not CT-derived body composition parameters, were relevant predictors for OS. As BMI can be altered, future research should investigate whether a high-calorie diet before or during PSMA RLT may improve OS.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcopenia / Prostatic Neoplasms, Castration-Resistant Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: J Nucl Med Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcopenia / Prostatic Neoplasms, Castration-Resistant Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: J Nucl Med Year: 2023 Document type: Article
...